Immunotherapy News and reporting on cancer immunotherapy. Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients. BostonGene, Abramson Cancer Center to Collaborate on Immunotherapy Studies The agreement will support multiple research projects at UPenn, beginning with a study of tumor-specific antigens for personalized cancer vaccine development. Freenome Eyes New Dx Possibilities for Core Technology as CRC Detection Trial Progresses Premium The firm continues to pursue new applications for its multiomics machine learning technology, with recent data exploring immunotherapy response prediction. Immunotherapy Response Data Spurs International Effort to Uncover Germline Polygenic Predictors Premium More than 45 centers are collaborating to uncover germline contributions to immunotherapy response and resistance and bring polygenic predictors to the clinic. Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow. Apr 12, 2021 Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor Apr 9, 2021 Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers Mar 30, 2021 Cleveland Clinic, IBM Partner on High-Performance Computing for Life Science, Healthcare Research Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 16, 2021 Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data Builds Premium Feb 25, 2021 Natera Revenues Grow 35 Percent in Q4 Feb 9, 2021 Germline Genetic Variants May Influence Tumor Immune Microenvironment, Treatment Response Feb 2, 2021 Oncocyte to Acquire Chronix Biomedical Jan 28, 2021 OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer Jan 20, 2021 Oncocyte to Raise $25M in Stock Sale to Institutional Investors Jan 4, 2021 Enpicom Sees Personalized Medicine Coming Into Focus After Busy 2020 Premium Dec 23, 2020 Personalis Sees New Neoantigen Platform Driving Improved Immunotherapy Prediction Premium Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Oct 23, 2020 Melanoma Treatment Stage Affects Ability of Liquid Biopsy to Predict Immunotherapy Benefit Premium Oct 16, 2020 Disparity in Microsatellite Instability Testing Suggests Need to Close Socioeconomic Access Gaps Premium Oct 8, 2020 Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction Oct 7, 2020 Immunotherapy Response Prediction Improved by Baseline, On-Treatment Biomarker Combo Premium Oct 6, 2020 BostonGene Collaborates With Transgene, NEC Corporation on Trials of Bespoke Cancer Vaccine Oct 1, 2020 Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology Sep 25, 2020 Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.